Marshall & Sullivan Inc. WA Has $5.33 Million Stake in Danaher Co. (NYSE:DHR)

Marshall & Sullivan Inc. WA increased its stake in shares of Danaher Co. (NYSE:DHR) by 1.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 23,226 shares of the conglomerate’s stock after acquiring an additional 356 shares during the quarter. Danaher comprises approximately 2.6% of Marshall & Sullivan Inc. WA’s holdings, making the stock its 16th largest holding. Marshall & Sullivan Inc. WA’s holdings in Danaher were worth $5,332,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Benjamin Edwards Inc. boosted its stake in shares of Danaher by 1.8% in the 2nd quarter. Benjamin Edwards Inc. now owns 2,153 shares of the conglomerate’s stock valued at $538,000 after purchasing an additional 38 shares during the last quarter. Wedge Capital Management L L P NC raised its position in shares of Danaher by 3.2% in the 3rd quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after acquiring an additional 38 shares during the period. Certified Advisory Corp boosted its stake in Danaher by 4.5% during the 2nd quarter. Certified Advisory Corp now owns 926 shares of the conglomerate’s stock worth $231,000 after acquiring an additional 40 shares during the last quarter. Meridian Financial Partners LLC increased its stake in Danaher by 4.4% in the third quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock valued at $266,000 after purchasing an additional 40 shares in the last quarter. Finally, Kovack Advisors Inc. raised its holdings in Danaher by 3.4% in the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock worth $346,000 after purchasing an additional 41 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the company. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Guggenheim started coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 price target for the company. StockNews.com cut shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. KeyCorp upped their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Finally, Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a research note on Wednesday, October 23rd. Six research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $286.80.

Danaher Trading Up 2.1 %

Shares of DHR traded up $4.85 during mid-day trading on Monday, reaching $239.92. 2,340,106 shares of the company were exchanged, compared to its average volume of 2,770,444. The business has a 50 day simple moving average of $235.67 and a two-hundred day simple moving average of $253.73. Danaher Co. has a 52 week low of $222.53 and a 52 week high of $281.70. The stock has a market capitalization of $173.29 billion, a PE ratio of 45.79, a PEG ratio of 4.32 and a beta of 0.83. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.57 by $0.14. The business had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.02 earnings per share. On average, analysts predict that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be paid a $0.27 dividend. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.